YLR271W Antibody

What is YLR271W and why are antibodies against it important for research?

YLR271W is a gene designation in Saccharomyces cerevisiae (baker's yeast) that encodes a specific protein. Antibodies targeting this protein are essential research tools for studying its expression, localization, interactions, and function within cellular systems. These antibodies enable visualization of the protein in various experimental contexts, including immunofluorescence, Western blotting, and immunoprecipitation. They serve as critical reagents for researchers investigating yeast cellular mechanisms, particularly in processes where this protein may play a significant role.

What types of YLR271W antibodies are available for research applications?

Researchers typically have access to several types of YLR271W antibodies, including monoclonal antibodies (derived from a single B-cell clone), polyclonal antibodies (derived from multiple B-cell clones), and recombinant antibodies (produced through molecular engineering). Each antibody type offers distinct advantages depending on the research application. Monoclonal antibodies provide high specificity for a single epitope, while polyclonal antibodies recognize multiple epitopes, potentially offering stronger signals but with greater cross-reactivity risk. Recombinant antibodies can be designed with customized properties for specific experimental needs .

How can I validate the specificity of a YLR271W antibody for my experiments?

Antibody validation requires multiple approaches to confirm specificity. For YLR271W antibodies, consider these validation methods:

• Testing with wild-type vs. YLR271W knockout strains in Western blots

• Peptide competition assays where the antibody is pre-incubated with purified YLR271W protein

• Immunoprecipitation followed by mass spectrometry to confirm target identity

• Using multiple antibodies targeting different epitopes of the same protein

• Testing for expected molecular weight, subcellular localization, and expression patterns

• Including appropriate positive and negative controls in all experiments

Validation should be performed in the specific experimental conditions and yeast strains you plan to use in your research .

What are the optimal conditions for using YLR271W antibodies in Western blotting?

For optimal Western blot results with YLR271W antibodies, consider these methodological recommendations:

• Sample preparation: Use a lysis buffer containing protease inhibitors specifically optimized for yeast cells. The typical protocol involves mechanical disruption with glass beads followed by detergent-based extraction.

• Protein loading: 10-30 μg of total protein per lane is generally sufficient, but this may vary based on expression levels.

• Blocking conditions: 5% non-fat dry milk or 3-5% BSA in TBST (Tris-buffered saline with 0.1% Tween-20) for 1 hour at room temperature.

• Primary antibody incubation: Dilute YLR271W antibody 1:500-1:5000 (optimize for each antibody) in blocking solution and incubate overnight at 4°C.

• Washing: Three 10-minute washes with TBST.

• Secondary antibody: Use species-appropriate HRP-conjugated secondary antibody at 1:5000-1:10,000 dilution for 1 hour at room temperature.

• Detection: Use ECL substrate and develop using a chemiluminescence imager such as an iBright 1500 system .

Always perform antibody titration experiments to determine the optimal concentration for your specific antibody and experimental conditions.

How can I optimize immunoprecipitation protocols using YLR271W antibodies?

For effective immunoprecipitation with YLR271W antibodies:

• Cell lysis: Use a gentle lysis buffer (typically containing 150 mM NaCl, 50 mM Tris-HCl pH 7.5, 1% NP-40 or IGEPAL, and protease inhibitors) optimized for preserving protein-protein interactions.

• Pre-clearing: Pre-clear lysates with protein A/G beads for 1 hour at 4°C to reduce non-specific binding.

• Antibody binding: Incubate 2-5 μg of YLR271W antibody with 500-1000 μg of pre-cleared lysate overnight at 4°C with gentle rotation.

• Bead capture: Add protein A/G beads and incubate for 2-4 hours at 4°C.

• Washing: Perform 4-5 washes with lysis buffer containing reduced detergent concentration.

• Elution: Elute bound proteins with SDS sample buffer at 95°C for 5 minutes.

• Analysis: Analyze by SDS-PAGE followed by Western blotting or mass spectrometry.

For co-immunoprecipitation of interaction partners, consider using chemical crosslinking to stabilize weaker interactions, and perform stringent controls including non-specific IgG and negative control immunoprecipitations .

What techniques can I use to study YLR271W localization in yeast cells?

To study YLR271W subcellular localization, consider these methodological approaches:

• Immunofluorescence microscopy:

  • Fix yeast cells with 3.7% formaldehyde

  • Digest cell walls with zymolyase or lyticase

  • Permeabilize with appropriate detergent (typically 0.1% Triton X-100)

  • Block with BSA solution

  • Incubate with primary YLR271W antibody (typically 1:100-1:500 dilution)

  • Apply fluorescently labeled secondary antibody

  • Counterstain with DAPI for nuclear visualization

  • Image using confocal or wide-field fluorescence microscopy

• GFP-tagging approach:

  • Create YLR271W-GFP fusion constructs using standard molecular techniques

  • Transform into yeast strains

  • Visualize in live cells or after fixation

  • Combine with organelle markers for colocalization studies

• Subcellular fractionation followed by Western blotting:

  • Separate cellular compartments using differential centrifugation

  • Analyze fractions by Western blotting with YLR271W antibody

  • Include compartment-specific marker proteins as controls

Each approach has strengths and limitations, so using multiple complementary techniques is recommended for robust localization data .

How can I use YLR271W antibodies for chromatin immunoprecipitation (ChIP) studies?

For effective ChIP experiments with YLR271W antibodies:

• Crosslinking: Fix yeast cells with 1% formaldehyde for 15-20 minutes at room temperature.

• Chromatin preparation:

  • Lyse cells using glass bead disruption in appropriate buffer

  • Shear chromatin to 200-500 bp fragments using sonication or enzymatic digestion

  • Verify shearing efficiency by agarose gel electrophoresis

• Immunoprecipitation:

  • Pre-clear chromatin with protein A/G beads

  • Incubate chromatin with 2-5 μg YLR271W antibody overnight at 4°C

  • Add protein A/G beads and incubate for 2-4 hours

  • Perform stringent washes with increasing salt concentrations

• Reversal of crosslinking and DNA purification:

  • Reverse crosslinks at 65°C overnight

  • Treat with proteinase K

  • Purify DNA using column-based methods

• Analysis:

  • Analyze by qPCR for specific genomic regions

  • Or proceed to library preparation for ChIP-seq

  • Include input controls, IgG controls, and positive control antibodies

Optimize antibody concentration and incubation conditions for each specific YLR271W antibody. For successful ChIP, ensure the antibody recognizes formaldehyde-fixed epitopes and consider performing pilot experiments with antibodies validated specifically for ChIP applications .

What approaches can I use to study post-translational modifications of YLR271W protein?

To study post-translational modifications (PTMs) of YLR271W:

• Using modification-specific antibodies:

  • Employ antibodies that specifically recognize phosphorylated, acetylated, ubiquitinated, or other modified forms of YLR271W

  • Validate specificity using appropriate controls (e.g., phosphatase treatment for phospho-specific antibodies)

  • Apply in Western blotting, immunoprecipitation, or immunofluorescence

• Mass spectrometry-based approaches:

  • Immunoprecipitate YLR271W using validated antibodies

  • Perform SDS-PAGE and extract the YLR271W band

  • Digest with trypsin or other proteases

  • Analyze by LC-MS/MS using PTM-specific methods

  • Consider enrichment strategies for specific modifications (e.g., TiO₂ for phosphopeptides)

• Combining immunoprecipitation with modification-specific detection:

  • Immunoprecipitate with general YLR271W antibody

  • Detect specific modifications by Western blotting with modification-specific antibodies

  • Or immunoprecipitate with modification-specific antibody and detect with general YLR271W antibody

• In vivo labeling approaches:

  • Metabolic labeling with ³²P for phosphorylation studies

  • SILAC labeling for quantitative proteomics approaches

Include appropriate controls for each experiment, such as treatment with modification-removing enzymes or mutation of putative modification sites .

How can I monitor YLR271W protein-protein interactions using antibody-based approaches?

To investigate YLR271W protein interactions, consider these methodological approaches:

• Co-immunoprecipitation (Co-IP):

  • Immunoprecipitate YLR271W using validated antibodies

  • Analyze co-precipitating proteins by Western blotting or mass spectrometry

  • Include appropriate controls: non-specific IgG, lysates from YLR271W deletion strains

  • Consider epitope masking issues that may occur in protein complexes

  • Use reversible crosslinking to capture transient interactions

• Proximity ligation assay (PLA):

  • Fix and permeabilize yeast cells

  • Incubate with primary antibodies against YLR271W and putative interacting partner

  • Apply PLA probes with oligonucleotide-conjugated secondary antibodies

  • Perform ligation and amplification steps

  • Visualize interaction signals by fluorescence microscopy

• FRET/FLIM using antibody-based fluorophores:

  • Label YLR271W antibody and interacting partner antibody with appropriate FRET pairs

  • Perform immunofluorescence and measure energy transfer

  • Calculate interaction distances based on FRET efficiency

• Bimolecular fluorescence complementation (BiFC) using epitope tags:

  • Create fusion constructs with split fluorescent protein fragments

  • Detect interaction through reconstitution of fluorescence

  • Validate with antibody detection of the individual proteins

Each method has specific advantages and limitations. Using multiple complementary approaches strengthens evidence for specific interactions .

What controls should I include when using YLR271W antibodies in my experiments?

Proper experimental controls are essential for reliable results with YLR271W antibodies:

• Negative controls:

  • YLR271W deletion/knockout strain lysates

  • Non-specific IgG of the same species and isotype as the YLR271W antibody

  • Secondary antibody only (omitting primary antibody)

  • Peptide competition assay (pre-incubation of antibody with excess antigen)

• Positive controls:

  • Purified recombinant YLR271W protein

  • Lysates from strains overexpressing YLR271W

  • Samples with known YLR271W expression patterns

  • Previously validated samples from published studies

• Specificity controls:

  • Multiple antibodies targeting different epitopes of YLR271W

  • Testing across multiple yeast strains or genetic backgrounds

  • Demonstration of expected molecular weight and subcellular localization

• Quantitative controls:

  • Loading controls for normalization (e.g., actin, GAPDH)

  • Dilution series to confirm signal linearity

  • Standardized positive samples across experiments for inter-experimental comparison

Including these controls helps distinguish specific from non-specific signals and enables confident interpretation of experimental results .

How can I resolve weak or absent signals when using YLR271W antibodies?

When encountering weak or absent signals with YLR271W antibodies, systematically troubleshoot using these approaches:

• Antibody-related factors:

  • Verify antibody quality and storage conditions (avoid repeated freeze-thaw cycles)

  • Optimize antibody concentration through titration experiments

  • Test multiple lots or sources of YLR271W antibodies

  • Consider whether the epitope might be masked by protein interactions or modifications

  • Ensure the antibody is compatible with your sample preparation method

• Sample preparation factors:

  • Ensure complete lysis of yeast cells (which have tough cell walls)

  • Add protease inhibitors to prevent degradation

  • Minimize time between sample preparation and analysis

  • Optimize protein extraction buffer components

  • Consider native vs. denaturing conditions based on epitope accessibility

• Technical optimization:

  • Increase protein loading amount

  • Extend primary antibody incubation time or temperature

  • Optimize blocking conditions to reduce background while preserving specific signal

  • Use more sensitive detection methods (e.g., enhanced chemiluminescence substrates)

  • Consider signal amplification systems like biotinylated secondary antibodies with streptavidin-HRP

• Biological factors:

  • Verify expression conditions for YLR271W (growth phase, media, stress conditions)

  • Consider whether the protein might be expressed at very low levels normally

  • Test conditions that might upregulate the protein of interest

Document all optimization steps methodically to identify which factors most significantly affect signal strength .

How can I address cross-reactivity issues with YLR271W antibodies?

When dealing with cross-reactivity issues in YLR271W antibody applications:

• Antibody specificity assessment:

  • Test the antibody on YLR271W deletion strain lysates to identify non-specific bands

  • Perform peptide competition assays to determine which signals are specific

  • Consider using alternative antibodies targeting different epitopes

  • For polyclonal antibodies, consider affinity purification against the specific antigen

• Experimental conditions optimization:

  • Increase stringency of washing steps (higher salt concentration, longer washes)

  • Adjust blocking conditions (try different blocking agents: milk, BSA, normal serum)

  • Optimize antibody dilution to reduce non-specific binding

  • Consider more stringent antigen retrieval methods for fixed samples

• Data analysis approaches:

  • Always include YLR271W knockout controls for accurate band identification

  • Document the molecular weight of all detected bands

  • Perform mass spectrometry analysis of ambiguous bands to confirm identity

  • Use densitometry to quantify specific bands while excluding non-specific signals

• Alternative approaches:

  • Consider epitope tagging of YLR271W and using tag-specific antibodies

  • Use multiple detection methods to corroborate findings

  • For critical experiments, consider generating new antibodies with improved specificity

Systematically document all cross-reactive bands and their behavior under different experimental conditions to develop reliable identification protocols .

How can I analyze YLR271W expression levels across different experimental conditions?

For robust analysis of YLR271W expression across conditions:

• Quantitative Western blotting approach:

  • Use infrared fluorescence-based detection systems for wider linear range

  • Include a standard curve of recombinant YLR271W protein

  • Normalize to multiple loading controls (not just one)

  • Use statistical methods to analyze biological and technical replicates

  • Present data as fold-change relative to control conditions

• Flow cytometry for single-cell analysis:

  • Fix and permeabilize yeast cells

  • Stain with fluorescently labeled YLR271W antibodies

  • Analyze population distributions rather than just means

  • Consider dual staining with cell cycle markers to assess cell-cycle dependence

• Quantitative immunofluorescence:

  • Use consistent acquisition parameters across all samples

  • Perform automated image analysis for unbiased quantification

  • Normalize to appropriate cellular markers

  • Analyze sufficient cells for statistical power (typically 100+ cells per condition)

• Correlation with mRNA levels:

  • Compare protein levels (by antibody detection) with mRNA levels (by RT-qPCR)

  • Analyze discrepancies that might indicate post-transcriptional regulation

Proper statistical analysis is essential: perform ANOVA with appropriate post-hoc tests for multiple conditions, and clearly report biological vs. technical replication strategies .

What methodological approaches can I use to study YLR271W dynamics and turnover?

To investigate YLR271W protein dynamics and turnover rates:

• Pulse-chase analysis:

  • Label newly synthesized proteins (e.g., with ³⁵S-methionine)

  • Chase with excess unlabeled amino acids

  • Immunoprecipitate YLR271W at various timepoints

  • Quantify signal decay to determine half-life

  • Include proteasome inhibitors to assess degradation pathways

• Cycloheximide chase assay:

  • Inhibit protein synthesis with cycloheximide

  • Collect samples at various timepoints

  • Detect YLR271W by Western blotting

  • Quantify protein decay rates under different conditions

• Fluorescence recovery after photobleaching (FRAP):

  • Create YLR271W-GFP fusion proteins

  • Photobleach a defined cellular region

  • Monitor fluorescence recovery over time

  • Calculate diffusion rates and immobile fractions

  • Validate findings with antibody-based approaches

• Ubiquitination analysis:

  • Immunoprecipitate YLR271W using specific antibodies

  • Detect ubiquitination by Western blotting with anti-ubiquitin antibodies

  • Or perform tandem ubiquitin binding entity (TUBE) pulldowns

  • Compare ubiquitination levels under various conditions

• Stability modulation:

  • Test effects of proteasome inhibitors (MG132, bortezomib)

  • Assess impact of lysosomal inhibitors (bafilomycin A1, chloroquine)

  • Examine effects of deubiquitinating enzyme inhibitors

These approaches can reveal regulatory mechanisms controlling YLR271W protein levels and activity .

How can I design multiplexed experiments to study YLR271W in relation to other proteins?

For multiplexed analysis of YLR271W and other proteins:

• Multiplex immunoblotting strategies:

  • Use antibodies from different species for simultaneous detection

  • Apply fluorescently labeled secondary antibodies with distinct spectral properties

  • Perform sequential probing with careful stripping between antibodies

  • Validate that stripping doesn't affect subsequent detection efficiency

  • Include appropriate controls for each antibody separately

• Multi-color immunofluorescence microscopy:

  • Select primary antibodies from different species

  • Use secondary antibodies with non-overlapping fluorescence spectra

  • Apply spectral unmixing algorithms for closely related fluorophores

  • Perform appropriate controls for bleed-through and cross-reactivity

  • Consider confocal or super-resolution approaches for colocalization studies

• Mass spectrometry-based multiplexing:

  • Immunoprecipitate YLR271W under various conditions

  • Apply isobaric labeling techniques (TMT, iTRAQ) for quantitative comparison

  • Analyze by LC-MS/MS to identify co-precipitating proteins

  • Use appropriate statistical methods for interactome analysis

  • Validate key interactions by reciprocal immunoprecipitation

• Single-cell multiplexing approaches:

  • Consider cyclic immunofluorescence (CycIF) for sequential staining

  • Apply computational analysis to correlate expression patterns at single-cell level

  • Validate with flow cytometry or mass cytometry approaches

These multiplexed approaches enable comprehensive analysis of YLR271W in its biological context, revealing functional relationships with other cellular components .

What quality control procedures should I implement when working with YLR271W antibodies?

Implement these quality control measures for robust YLR271W antibody experiments:

Regularly performing these quality control procedures ensures experimental reliability and facilitates troubleshooting when unexpected results occur. Document all procedures in laboratory notebooks and include quality control data in publications .

How can I ensure reproducibility when using different lots or sources of YLR271W antibodies?

To ensure reproducibility across antibody lots or sources:

• Antibody characterization and documentation:

  • Maintain detailed records of antibody sources, catalog numbers, and lot numbers

  • Document the immunogen used to generate each antibody

  • Characterize each new lot against standard samples before use in critical experiments

  • Create a laboratory antibody database tracking performance metrics

• Reference standards implementation:

  • Maintain aliquots of standard samples (e.g., wild-type lysate, recombinant protein)

  • Test each new antibody lot against these standards

  • Document and quantify any performance differences

  • Consider creating an internal reference standard curve

• Bridging studies when changing antibodies:

  • Run side-by-side comparisons with old and new antibody lots

  • Determine conversion factors if quantitative differences exist

  • Document the transition in laboratory records

  • Consider re-analyzing key samples with both antibodies

• Long-term reproducibility strategies:

  • Purchase larger quantities of well-performing lots when possible

  • Aliquot antibodies to minimize freeze-thaw cycles

  • Consider generating recombinant antibodies for long-term stability

  • Develop detailed standard operating procedures (SOPs) for each application

These practices help maintain experimental consistency over time and facilitate comparison of results across studies .

What are best practices for documenting antibody-based experiments with YLR271W for publication?

For publication-quality documentation of YLR271W antibody experiments:

• Antibody reporting standards:

  • Provide complete antibody identification information:

    • Commercial source and catalog number

    • Clone number for monoclonal antibodies

    • Lot number (particularly for polyclonal antibodies)

    • RRID (Research Resource Identifier) when available

    • Host species and antibody isotype

    • Immunogen used to generate the antibody

  • Include detailed methods for custom antibodies

• Experimental condition documentation:

  • Report exact dilutions or concentrations used

  • Document blocking agents and durations

  • Specify washing conditions (buffer composition, number and duration of washes)

  • Indicate incubation times and temperatures

  • Describe detection methods in detail

• Validation evidence inclusion:

  • Provide validation data (knockout controls, peptide competition)

  • Include all relevant controls in figures or supplementary materials

  • Show full blots or images with molecular weight markers

  • Describe image acquisition and processing methods

• Quantification methodology:

  • Explain normalization approach

  • Describe software used for quantification

  • Report statistical methods and sample sizes

  • Indicate whether technical or biological replicates

  • Provide raw data in supplementary materials when possible

Following these practices enhances experimental transparency and enables other researchers to build upon your findings .

How can I apply emerging antibody technologies to YLR271W research?

Emerging technologies offer new opportunities for YLR271W research:

• Single-domain antibodies and nanobodies:

  • Smaller size enables access to restricted epitopes

  • Enhanced stability for challenging conditions

  • Potential for improved penetration in fixed yeast cells

  • Consider nanobody-based approaches for live-cell imaging

  • Protocols for nanobody selection can be adapted for YLR271W targets

• Recombinant antibody technologies:

  • Generate sequence-defined antibodies for consistent performance

  • Explore antibody engineering for custom properties

  • Consider bispecific antibodies for co-detection of interacting partners

  • Libraries like PLAbDab provide resources for antibody development

• Proximity-dependent labeling approaches:

  • Fuse antibody fragments to enzymes like TurboID or APEX2

  • Apply to living cells to map protein neighborhoods

  • Identify context-dependent interaction partners

  • Validate findings with traditional co-immunoprecipitation

• Super-resolution microscopy with antibody-based detection:

  • Apply STORM, PALM, or STED microscopy for nanoscale localization

  • Use appropriate fluorophore-conjugated antibodies optimized for super-resolution

  • Combine with expansion microscopy for enhanced resolution

  • Employ quantitative analysis of spatial distribution patterns

These emerging approaches can provide unprecedented insights into YLR271W function, localization, and interactions in cellular contexts .

What computational tools can enhance YLR271W antibody-based research?

Computational tools can significantly enhance antibody-based research:

• Epitope prediction and antibody design tools:

  • Apply computational epitope mapping to identify accessible regions

  • Use tools like ESM-1b for antibody sequence optimization

  • Predict antibody-antigen interactions using AlphaFold-Multimer

  • Evaluate binding energies with Rosetta-based tools

• Image analysis platforms for immunofluorescence:

  • Employ machine learning algorithms for automated cell detection

  • Use segmentation tools to quantify subcellular localization

  • Apply colocalization analysis software with appropriate statistical metrics

  • Consider open-source platforms like CellProfiler or ImageJ/Fiji

• Proteomic data analysis for antibody-based pulldowns:

  • Implement statistical methods to distinguish specific from non-specific interactions

  • Apply network analysis to place YLR271W in functional contexts

  • Use tools like SAINT or CompPASS for scoring interaction confidence

  • Integrate with existing protein interaction databases

• Sequence and structure analysis:

  • Leverage databases like PLAbDab to identify similar antibodies

  • Compare YLR271W across species to identify conserved epitopes

  • Use structural prediction to identify accessible protein regions

  • Apply molecular dynamics simulations to understand epitope flexibility

These computational approaches can guide experimental design, enhance data interpretation, and generate new hypotheses about YLR271W function .

What methodological advances are improving reproducibility in antibody-based research?

Recent methodological advances enhancing reproducibility include:

• Recombinant antibody technologies:

  • Sequence-defined antibodies eliminate lot-to-lot variation

  • Stable cell lines producing consistent antibodies

  • Genetic encoding of complete antibody sequences

  • Community initiatives to replace poorly defined antibodies with recombinant versions

• Standardized validation methods:

  • Implementation of multi-tier validation strategies

  • Application-specific validation requirements

  • Use of knockout/knockdown controls as gold standard

  • Comprehensive reporting in publications and databases

• Automated experimental systems:

  • Robotic liquid handling for consistent antibody dilutions

  • Automated staining platforms for immunohistochemistry

  • Standardized image acquisition parameters

  • Microfluidic approaches for reduced sample requirements

• Open science initiatives:

  • Antibody validation repositories with experimental evidence

  • Research Resource Identifiers (RRIDs) for tracking antibody use

  • Detailed protocol sharing on platforms like protocols.io

  • Raw data deposition in appropriate repositories

• Data analysis standardization:

  • Open-source analysis pipelines with version control

  • Blinded analysis approaches

  • Statistical power calculations for appropriate sample sizes

  • Machine learning for unbiased image analysis

These advances collectively improve the reliability and reproducibility of antibody-based research, including studies involving YLR271W antibodies .